HIV Prevention: Access and Innovation in Latin America
Explore lenacapavir’s promising efficacy for HIV prevention through twice-yearly shots. Discuss barriers to access, including pricing strategies by Gilead Sciences and efforts from activists and governments. Learn about alternative approaches like alimatravir and the role of long-acting PrEP in combating HIV.📥 Connect with The Well-Built LifeIf you enjoyed today’s conversation, please take a moment to follow or subscribe to the channel on your favorite platform so you never miss a practical health and wellness tip.Spreaker: Spreaker Podcast LinkBusiness Inquiries: Contact Us☕ Support the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.